Houston, TX, United States of America

Nancy T Chang

USPTO Granted Patents = 22 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 240(Granted Patents)


Location History:

  • Paoli, PA (US) (1986 - 1988)
  • Houston, TX (US) (1989 - 2016)

Company Filing History:


Years Active: 1986-2016

Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations in Biotechnology: The Contributions of Nancy T. Chang

Introduction

Nancy T. Chang is a prominent inventor based in Houston, TX, who has significantly advanced the field of biotechnology through her groundbreaking research and numerous patents. With a remarkable portfolio of 22 patents, her work has had a profound impact on the understanding and detection of viral infections, particularly HIV and HTLV-III.

Latest Patents

Among Nancy T. Chang's latest innovations are two pivotal patents focused on the cloning and expression of virus DNA. The first patent involves the determination of the nucleotide sequence of HIV-1 DNA, detailing the identification, isolation, and expression of sequences encoding immunoreactive polypeptides through recombinant DNA methods. These polypeptides play a crucial role in developing immunoassays for the detection of HIV-1. Similarly, her second patent addresses HTLV-III DNA, contributing to the identification and isolation of sequences that can also be utilized in immunoassays to detect this particular virus.

Career Highlights

Nancy has made significant contributions while working for various companies, including Tanox Biosystems, Inc. and Centocor, Inc. Her tenure at these institutions has enhanced her research capabilities and allowed her to collaborate with other brilliant minds in the field of biotechnology. Her dedication to innovation has placed her at the forefront of research in viral detection and treatment strategies.

Collaborations

Through her career, Nancy Chang has collaborated with esteemed professionals such as Tse W. Chang and Robert C. Gallo. These partnerships have led to important findings in the fight against viral infections, further advancing the development of new diagnostic methods and therapies.

Conclusion

Nancy T. Chang’s contributions to biotechnology showcase her talent and commitment to innovation. With a strong patent portfolio and impactful collaborations, she continues to shape the future of viral research, making significant strides in the detection and treatment of infectious diseases. Her work not only benefits the scientific community but also enhances public health outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…